New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant s

New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant systemic sclerosis. New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.

• Ponto de atenção: data.
• Ponto de atenção: highlight.
• Ponto de atenção: shelf.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.